These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3145550)

  • 41. Characterization of an IgG2, G2m(23) anti-Rh-D antibody.
    Dugoujon JM; de Lange GG; Blancher A; Alie-Daram S; Marty Y
    Vox Sang; 1989; 57(2):133-6. PubMed ID: 2506693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obtaining a functional recombinant anti-rhesus (D) antibody using the baculovirus-insect cell expression system.
    Edelman L; Margaritte C; Chaabihi H; Monchâtre E; Blanchard D; Cardona A; Morin F; Dumas G; Petres S; Kaczorek M
    Immunology; 1997 May; 91(1):13-9. PubMed ID: 9203960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody dependent cell mediated cytotoxicity against anti-D sensitized human erythrocytes. Influence of various effector cells and enzyme treatment of the target cells.
    Samdal HH; Michaelsen TE; Heier HE; Nordhagen R
    APMIS; 1988 Mar; 96(3):250-6. PubMed ID: 3126786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting of erythrocytes to cytotoxic T-cells.
    Chiarantini L; Droleskey R; Magnani M; Kirch H; DeLoach JR
    Adv Exp Med Biol; 1992; 326():257-67. PubMed ID: 1295314
    [No Abstract]   [Full Text] [Related]  

  • 45. Segregation of Rh 1(D) and Rh 25(LW) antigens of human Rh blood groups from the Triton-treated fetal erythrocyte membranes.
    Fukushima H; Segawa M; Ota M; Yonemura I; Hiraide K; Hasekura H
    Nihon Hoigaku Zasshi; 1986 Apr; 40(2):101-4. PubMed ID: 3097360
    [No Abstract]   [Full Text] [Related]  

  • 46. A Japanese Rhmod family: serological and haematological observations.
    Saji H; Hosoi T
    Vox Sang; 1979; 37(5):296-304. PubMed ID: 118585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Results with the group 3 antibodies.
    Von dem Borne AE
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):203-8. PubMed ID: 3145549
    [No Abstract]   [Full Text] [Related]  

  • 48. Antigens on red cells.
    Anstee DJ
    Vox Sang; 1998; 74 Suppl 2():255-7. PubMed ID: 9704453
    [No Abstract]   [Full Text] [Related]  

  • 49. Monoclonal antibodies against Rh and Rh related antigens.
    Tippett P; Moore S
    J Immunogenet; 1990; 17(4-5):309-19. PubMed ID: 1709670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How do I manage Rh typing in obstetric patients?
    Haspel RL; Westhoff CM
    Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
    [No Abstract]   [Full Text] [Related]  

  • 51. Serological investigation of Rh antibodies other than anti-D.
    Delsalle A; Bendik B; Mannessier L
    Transfus Clin Biol; 1996; 3(6):381-4. PubMed ID: 9018793
    [No Abstract]   [Full Text] [Related]  

  • 52. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of producer cell line on functional activity of anti-D monoclonal antibodies destined for prevention of rhesus sensitization.
    Olovnikova NI; Ershler MA; Belkina EV; Nikolaeva TL; Miterev GY
    Bull Exp Biol Med; 2009 Apr; 147(4):448-52. PubMed ID: 19704946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specificity C and e: tests using Rh variant cells.
    Smart EA; Reddy V
    Transfus Clin Biol; 1996; 3(6):355-7. PubMed ID: 9018788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system].
    León-González G; Cruz C
    Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of enzyme-treated red blood cell surface and haemagglutination using a theory of soft-particle electrophoresis.
    Hyono A; Mazda T; Okazaki H; Tadokoro K; Ohshima H
    Vox Sang; 2008 Aug; 95(2):131-6. PubMed ID: 18510578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibodies with specificities related to the Kell blood group system.
    Parsons SF; Judson PA; Spring FA; Mallinson G; Anstee DJ
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):401-5. PubMed ID: 3212321
    [No Abstract]   [Full Text] [Related]  

  • 58. A serologic weakly reactive RhD is caused by a novel RHD (c.722C>A, p.Thr241Asn) allele.
    Xie H; Yang X; Zhu S; Lin H; Chen F
    Transfusion; 2021 Apr; 61(4):E31-E33. PubMed ID: 33720432
    [No Abstract]   [Full Text] [Related]  

  • 59. Two examples of an inseparable antibody that reacts equally well with DW+ and Rh32+ red blood cells.
    Reid ME; Sausais L; Zaroulis CG; Mohandas K; Coghlan G; Lomas-Francis C
    Vox Sang; 1998; 75(3):230-3. PubMed ID: 9852412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and partial characterization of the human erythrocyte membrane component(s) that express the antigens of the LW blood-group system.
    Mallinson G; Martin PG; Anstee DJ; Tanner MJ; Merry AH; Tills D; Sonneborn HH
    Biochem J; 1986 Mar; 234(3):649-52. PubMed ID: 2424433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.